Claro Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Claro Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500	Closed	-$9K	–	1103
2018 Q4	$9K	Buy	+500	New	+$11K	0.01%	708

Claro Advisors's ECYT Position: Q1 2019 in Review

Claro Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2019, closing a stake of 500 shares — an estimated $9K sold.

Claro Advisors first reported a position in ECYT in Q4 2018 and held it in 1 quarter. The position peaked at $9K in Q4 2018. 0 funds tracked by Wall St. Rank hold ECYT as of Q1 2019.

Claro Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 500 Endocyte, Inc. Common Stock shares in Q1 2019, an estimated $9K.
Claro Advisors first reported a position in Endocyte, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
Claro Advisors's Endocyte, Inc. Common Stock position peaked at $9K in Q4 2018.
0 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.